Unicycive Therapeutics (UNCY) traded down -1.27 % during a 24 hours period ending at 11:03 PM Central Europe on Monday 26th. One Unicycive Therapeutics stock can currently be bought for about USD 3.58 on popular exchanges. Current supply of Unicycive Therapeutics stocks is 27.9 mn. Unicycive Therapeutics has a current market capitalization of USD 108.4 mn and approximately USD 4.7 mn worth of Unicycive Therapeutics was traded on exchanges in the last 24 hours. Since last month end, Unicycive Therapeutics has traded -19.13 % down. Simple moving average of last 200 days is at USD 6.16. The highest price of past 52 weeks was recorded at USD 8.74 on 05/14/2026. 52 weeks low was at USD 3.35 on 10/16/2026.
Here is how related stocks have performed in the past 24 hours:
Comstock (LODE) traded down -5 % and now trades at USD 1.69. Comstock has a market capitalisation of USD 130 mn.
Organogenesis (ORGO) traded down -3.59 % and now trades at USD 0.94. Current market capitalisation for Organogenesis is USD 127.8 mn.
Nkarta (NKTX) traded up 2.87 % and now trades at USD 1.83. Current market capitalisation for Nkarta is USD 128.2 mn.
Futurewave Acquisition Cor (FWACU) traded flat 0 % and now trades at USD 10.1. Futurewave Acquisition Cor has a market capitalisation of USD 127.8 mn.
Spruce Biosciences (SPRB) traded down -1.85 % and now trades at USD 43.99. Current market capitalisation for Spruce Biosciences is USD 129.8 mn.
About Unicycive Therapeutics
Unicycive Therapeutics, Inc. is a biotechnology company based in Los Altos, United States, that specializes in the development of two novel therapies for treating hyperphosphatemia in patients with chronic kidney disease and acute kidney injury.
